Smart Pills Market 2020 Global Industry Analysis, Emerging Trends, Product Value, Growth, Demand, Gross Margin, Revenue And Forecast To 2028
According to our latest study, "Smart Pills Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Application, Disease Indication, and End User," the market is expected to grow from US$ 4,019.30 million in 2021 to US$ 9,061.29 million by 2028; it is estimated to grow at a CAGR of 12.3% from 2021 to 2028. The report highlights the key factors driving the market and prominent players with their developments. The growth of the smart pills market is primarily due to the increase in strategic collaborations & partnerships on smart pills and rising demand for minimally invasive surgical procedures. However, the high cost of smart pills hampers the smart pills market's growth.
The COVID-19 pandemic led to an
increase in smart pill tests and innovations due to industry players' constant
endeavor towards developing products that could help in combating the disease.
For instance, in November 2021, the UK approved a potentially game-changing
SARS-CoV-2 antiviral pill to fight the Covid-19 pandemic. The drug molnupiravir
was recommended by Britain’s MHRA (Medicines and Healthcare products Regulatory
Agency) for use in people with mild to moderate COVID-19.
Explore
Premium Report on Smart Pills Market at:
https://www.theinsightpartners.com/sample/TIPHE100001238/
Based on application, the smart pills
market is segmented into capsule endoscopy, drug delivery, and patient
monitoring. In 2021, capsule endoscopy segment held the largest market share.
However, drug delivery is estimated to grow at the fastest CAGR of 13.4% during
the forecast period. Moreover, the capsule endoscopy segment is segmented into
small bowel video capsule endoscopy, colon capsule endoscopy, controllable
capsule endoscopy, storable capsule endoscopy, and other capsule endoscopy. In
2021, the small bowel video capsule endoscopy segment held the largest market
share of the smart pills market by capsule endoscopy; however, colon capsule
endoscopy is estimated to register the highest CAGR of 12.4% during the forecast
period. The largest share of this segment is due to the higher preference for
technological developments in the capsule endoscopes. Smart pills emerged as a
revolutionary technological innovation, bridging digital technology and
healthcare. The advent of these healthcare-cum-technological devices enabled
addressing soaring demand for better monitoring and diagnostics.
CapsoVision, Inc.; Medtronic.; Check-Cap; PENTAX Medical;
Olympus Corporation; BodyCap.; Otsuka America Pharmaceutical, Inc.; IntroMedic;
Jinshan Science & Technology (Group) Co., Ltd.; and RF Co., Ltd. are a few
leading companies operating in the smart pills market.
About Us:
The Insight Partners is a one stop industry research
provider of actionable intelligence. We help our clients in getting solutions
to their research requirements through our syndicated and consulting research
services. We specialize in industries such as Semiconductor and Electronics,
Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare
IT, Manufacturing and Construction, Medical Device, Technology, Media and
Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would
like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Comments
Post a Comment